Psyence Biomedical Warrant
PBMWW
23 hedge funds and large institutions have $142K invested in Psyence Biomedical Warrant in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
15% more capital invested
Capital invested by funds: $124K → $142K (+$18.6K)
0% more funds holding
Funds holding: 23 → 23 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
3.1% less ownership
Funds ownership: 46.83% → 43.74% (-3.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$4.69K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2.52K |
| 3 |
VF
Virtu Financial
New York
|
+$384 |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11 |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
-$9.51K |
| 2 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$1.56K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$744 |
| 4 |
PA
Parallel Advisors
San Francisco,
California
|
-$567 |
PBMWW Hedge Fund Activity: Q3 2025 in Review
23 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical Warrant (PBMWW) for Q3 2025, worth a combined $142K — up 15% from $124K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PBMWW positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Clear Street, adding an estimated $4.69K. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $9.51K sold.
- 23 institutional investors held Psyence Biomedical Warrant (PBMWW) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $142K of Psyence Biomedical Warrant stock for Q3 2025, up 15% quarter-over-quarter.
- 3 funds opened new Psyence Biomedical Warrant positions in Q3 2025 and 2 closed out, a net change of +1 holder.
- The largest Psyence Biomedical Warrant buyer in Q3 2025 was Clear Street, an estimated $4.69K added.
- The largest Psyence Biomedical Warrant seller in Q3 2025 was Cantor Fitzgerald, an estimated $9.51K sold.
Based on aggregated 13F filings for Q3 2025.